Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the Top 10 Stocks Under $10 That Could Triple. On August 19, H.C. Wainwright reaffirmed its Buy rating for Iovance Biotherapeutics, Inc.

WASHINGTON — National Guard troops deployed to Washington this month to support President Donald Trump's effort to mitigate crime began carrying firearms Sunday evening, according to the federal task ...

Intruder, a leader in attack surface management, is releasing Autoswagger—a free, open-source tool that scans OpenAPI-documented APIs for broken authorization vulnerabilities. According to the company ...

CELEBRATION, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with ...

CSOs are being urged to quickly patch multiple vulnerabilities in Cisco Systems Identity Services Engine (ISE) and Cisco ISE Passive Identity Connector (ISE-PIC) that could allow an unauthenticated, ...

CHAMPAIGN, Ill. (WAND) - Champaign County employees are conducting a strike authorization vote on May 27 and 28 to push for a fair union contract after nearly 150 days without a new agreement since ...

Concurrent review is a utilization review process that occurs while a patient is actively receiving treatment, such as during a hospital stay. It evaluates the medical necessity and appropriateness of ...

Gov. Mark Gordon signed 18 bills into law. Among the bills signed Monday was one that will make changes to a process health insurance companies use to approve or deny medications for patients and one ...